BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12687504)

  • 21. Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA.
    O'Donnell JL; Hayman MW; Spellerberg MB; McLellan AD; Brooksbank K; Chapman PT; Stamp LK
    Pathology; 2007 Apr; 39(2):258-63. PubMed ID: 17454758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antineutrophil cytoplasmic antibodies (ANCA).
    Radice A; Sinico RA
    Autoimmunity; 2005 Feb; 38(1):93-103. PubMed ID: 15804710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
    Finkielman JD; Lee AS; Hummel AM; Viss MA; Jacob GL; Homburger HA; Peikert T; Hoffman GS; Merkel PA; Spiera R; St Clair EW; Davis JC; McCune WJ; Tibbs AK; Ytterberg SR; Stone JH; Specks U;
    Am J Med; 2007 Jul; 120(7):643.e9-14. PubMed ID: 17602941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antineutrophil cytoplasmic antibody (ANCA) testing of routine sera varies in different laboratories but concordance is greater for cytoplasmic fluorescence (C-ANCA) and myeloperoxidase specificity (MPO-ANCA).
    Pollock W; Jovanovich S; Savige J
    J Immunol Methods; 2009 Aug; 347(1-2):19-23. PubMed ID: 19490915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations.
    Fauzi AR; Kong NC; Chua MK; Jeyabalan V; Idris MN; Azizah R
    Med J Malaysia; 2004 Aug; 59(3):372-7. PubMed ID: 15727383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
    Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis.
    Wiesner O; Russell KA; Lee AS; Jenne DE; Trimarchi M; Gregorini G; Specks U
    Arthritis Rheum; 2004 Sep; 50(9):2954-65. PubMed ID: 15457464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of anti-neutrophil cytoplasmic antibodies with proteinase 3 specificity by immunoblotting].
    Chevailler A; Taouil K; Carrère F; Renier G; Hurez D
    Pathol Biol (Paris); 1994 Jun; 42(6):575-80. PubMed ID: 7854857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
    Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
    Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis.
    Zhou Y; Huang D; Farver C; Hoffman GS
    J Rheumatol; 2003 Jul; 30(7):1541-7. PubMed ID: 12858455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay.
    Roggenbuck D; Buettner T; Hoffmann L; Schmechta H; Reinhold D; Conrad K
    Ann N Y Acad Sci; 2009 Sep; 1173():41-6. PubMed ID: 19758130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum.
    Nifli AP; Notas G; Mamoulaki M; Niniraki M; Ampartzaki V; Theodoropoulos PA; Kopnitsky MJ; Castanas E
    J Immunol Methods; 2006 Apr; 311(1-2):189-97. PubMed ID: 16554066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen-specific ANCA ELISAs have different sensitivities for active and treated vasculitis and for nonvasculitic disease.
    Trevisin M; Pollock W; Dimech W; Melny J; Paspaliaris B; Gillis D; Wong R; Savige J
    Am J Clin Pathol; 2008 Jan; 129(1):42-53. PubMed ID: 18089488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA).
    Savige J; Gillis D; Benson E; Davies D; Esnault V; Falk RJ; Hagen EC; Jayne D; Jennette JC; Paspaliaris B; Pollock W; Pusey C; Savage CO; Silvestrini R; van der Woude F; Wieslander J; Wiik A
    Am J Clin Pathol; 1999 Apr; 111(4):507-13. PubMed ID: 10191771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status.
    Comfere NI; Macaron NC; Gibson LE
    J Cutan Pathol; 2007 Oct; 34(10):739-47. PubMed ID: 17880578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region.
    Gibson A; Stamp LK; Chapman PT; O'Donnell JL
    Rheumatology (Oxford); 2006 May; 45(5):624-8. PubMed ID: 16368729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antineutrophil cytoplasmic antibodies (ANCA): clinico-pathologic correlations iin a series of 82 cases].
    Calvo Romero JM; Romero Requena J; Arévalo Lorido JC; Ramos Salado JL; Doblaré Castellano E; Vargas Pérez ML; Bureo Dacal P; Pérez Miranda M
    An Med Interna; 2002 Jan; 19(1):7-10. PubMed ID: 11989089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus in childhood.
    Faure-Fontenla MA; Rodríguez-Suárez RS; Arias-Velásquez R; García-González JE
    J Rheumatol; 1999 Nov; 26(11):2480-1. PubMed ID: 10555913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence and specificity of antineutrophil cytoplasmic antibodies (ANCA) in connective tissue diseases].
    Puszczewicz M; Zimmermann-Górska I; Białkowska-Puszczewicz G; Tuchocka A
    Pol Arch Med Wewn; 2003 Jan; 109(1):35-41. PubMed ID: 12879764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.